Clinical Trials in Guangdong, China
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Triple-Negative Breast CancerEndometrial CancerPrimary Peritoneal Carcinoma+12 more
Genmab764 enrolled67 locationsNCT05579366
Recruiting
Lecanemab for Early Onset Familial Alzheimer's Disease
Alzheimer Disease
RenJi Hospital114 enrolled15 locationsNCT06883019